Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics
Ribometrix Further Expands Leadership with Appointment of Barclay “Buck” Phillips as Chief Operating Officer and Chief Financial Officer
Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics